Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_assertion type Assertion NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_head.
- NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_assertion description "[In contrast, CTGF in patients with poor prognosis (P = 0.021), metastasis (P = 0.012), local recurrence (P = 0.0024) and mortality (P = 0.0072) had markedly reduced levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_provenance.
- NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_assertion evidence source_evidence_literature NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_provenance.
- NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_assertion SIO_000772 15613452 NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_provenance.
- NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_assertion wasDerivedFrom befree-20150227 NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_provenance.
- NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_assertion wasGeneratedBy ECO_0000203 NP334686.RAoEfX4MHrf46cYgTw5yL125GEWsfsVXXgoTAq9G5KIFY130_provenance.